Batista-Gonzalez, A., Vidal, R., Criollo, A
Semaglutide (Ozempic, Wegovy, Rybelsus) Semaglutide is a GLP-1 receptor agonist available under brand names such as Ozempic (for type 2 diabetes), Wegovy (for obesity), and Rybelsus (an oral form)
Headaches, fatigue, and minor blood sugar changes may also occur
Standard AOD-9604 Dosing : Dose: 0.20.3 mg per injection Frequency: Once or twice daily Timing: Morning: Ideally before fasted cardio or 12 hours before breakfast Evening: 13 hours after dinner, before bedtime Targeting Fat Loss Inject into areas with stubborn fat (e.g., abdomen, thighs) Best results occur when combined with exercise and a clean diet Cycle Duration : Loading Phase: 46 weeks of daily use Maintenance Phase: 23 injections per week to sustain results Breaks: Optional 12 week breaks every few months to avoid receptor desensitization Why Timing Matters : Administering AOD-9604 on an empty stomach enhances absorption Pairing with fasted cardio may amplify lipolytic effects Side Effects to Watch For : Mild nausea Headaches Localized irritation at injection site These are rare and typically resolve quickly

AOD9604 might be perfect for your lab if youre researching: This selective peptide has already been studied in all of these areas, but the most exciting breakthroughs are still waiting for the right science team
Easy refill and quick delivery